Funding for this research was provided by:
National Natural Science Foundation of China (U1932145, 82002946)
Science and Technology Commission of Shanghai Municipality (18401933402)
Shanghai Sailing Program (19YF1409500)
Received: 10 August 2021
Accepted: 12 October 2021
First Online: 26 October 2021
: All study protocols were approved by the ethics committee of the Fudan University Shanghai Cancer Center, Shanghai Cancer Center Institutional Review Board (SCCIRB), and in accordance with international standards of good clinical practice. Written informed consents were provided by all patients.
: The content of this manuscript has not been previously published and is not under consideration for publication elsewhere.
: Wanxiangfu Tang, Hua Bao, Rui Liu, Shuyu Wu, Hairong Bao, Xue Wu and Yang Shao are employees of Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China. The remaining authors have nothing to declare.